| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 14.668 | 29.148 | 12.914 | 9.495 | 18.905 | 26.576 | 71.487 | 100.592 |
| Total Income - EUR | - | - | 14.668 | 29.148 | 12.914 | 11.509 | 18.905 | 26.576 | 76.842 | 134.782 |
| Total Expenses - EUR | - | - | 2.726 | 10.454 | 5.519 | 5.785 | 7.279 | 8.585 | 47.980 | 74.740 |
| Gross Profit/Loss - EUR | - | - | 11.942 | 18.694 | 7.395 | 5.723 | 11.626 | 17.992 | 28.863 | 60.043 |
| Net Profit/Loss - EUR | - | - | 11.502 | 17.866 | 7.049 | 5.473 | 11.239 | 17.486 | 28.508 | 56.815 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Sonoglandmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 13 | 0 | 0 | 670 | 5.940 | 5.009 | 120.615 | 86.377 |
| Current Assets | - | - | 11.758 | 18.307 | 7.977 | 5.247 | 11.496 | 36.282 | 22.375 | 52.368 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 49 | 13.265 | 6.987 | 1.935 | 4.097 | 13.936 | 12.128 | 10.011 |
| Cash | - | - | 11.709 | 5.042 | 991 | 3.311 | 7.398 | 22.346 | 10.247 | 42.357 |
| Shareholders Funds | - | - | 11.546 | 17.918 | 7.100 | 5.523 | 16.618 | 17.534 | 34.826 | 77.697 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 226 | 389 | 954 | 394 | 818 | 23.757 | 108.163 | 20.375 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.674 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sonoglandmed Srl